Cargando…

Effectiveness, Adverse Events, and Immune Response Following Double Vaccination with BNT162b2 in Staff at the National Comprehensive Cancer Center (NCCC)

Vaccination remains the leading strategy against COVID-19 worldwide. BNT162b2 is among the first licensed vaccines with high effectiveness. However, the role of antibody and cell immunity response monitoring after vaccination remains unclear. We conducted a 6-month prospective study involving the em...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palacka, Patrik, Pol’anová, Monika, Svobodová, Alena, Žigmond, Jan, Zanchetta, Katarína, Gombárová, Vlasta, Vulganová, Martina, Slopovský, Ján, Obertová, Jana, Drgoňa, Ľuboš, Mego, Michal, Pechan, Juraj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026370/ https://www.ncbi.nlm.nih.gov/pubmed/35455308 http://dx.doi.org/10.3390/vaccines10040558

Ejemplares similares

A case report of a patient with inoperable primary diffuse leptomeningeal melanomatosis treated with whole-brain radiotherapy and pembrolizumab
por: Palacka, Patrik, et al.
Publicado: (2022)

Plasma thiobarbituric acid reactive substances predicts survival in chemotherapy naïve patients with metastatic urothelial carcinoma
por: Slopovsky, Jan, et al.
Publicado: (2020)

Changes in CoQ(10)/Lipids Ratio, Oxidative Stress, and Coenzyme Q(10) during First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma (mUC)
por: Palacka, Patrik, et al.
Publicado: (2022)

Pericardial malignant infiltration as the cause of sudden death of a patient with metastatic urothelial carcinoma treated with atezolizumab
por: Palacka, Patrik, et al.
Publicado: (2022)

Platelet Mitochondrial Bioenergetics Reprogramming in Patients with Urothelial Carcinoma
por: Palacka, Patrik, et al.
Publicado: (2021)

Factors Associated With Choriocarcinoma Syndrome Development in Poor-Risk Patients With Germ Cell Tumors
por: Rejlekova, Katarina, et al.
Publicado: (2022)

Effects of primary granulocyte-colony stimulating factor prophylaxis on the incidence of febrile neutropenia in patients with germ cell tumors
por: Hapakova, Nikola, et al.
Publicado: (2022)

NCCC308: Nutrition and Management of Feedlot Cattle to Optimize Performance, Carcass Value, and Environmental Compatibility – Feature Collection - Nutrition and Management of Finishing Cattle
por: Swanson, Kendall C, et al.
Publicado: (2023)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)

Comprehensive Assessment of Selected Immune Cell Subpopulations Changes in Chemotherapy-Naïve Germ Cell Tumor Patients
por: Kalavska, Katarina, et al.
Publicado: (2022)

Detection of Specific Immune Cell Subpopulation Changes Associated with Systemic Immune Inflammation–Index Level in Germ Cell Tumors
por: Kalavska, Katarina, et al.
Publicado: (2022)

Probiotic Survey in Cancer Patients Treated in the Outpatient Department in a Comprehensive Cancer Center
por: Ciernikova, Sona, et al.
Publicado: (2016)

The prognostic value of DNA damage level in peripheral blood lymphocytes of chemotherapy-naïve patients with germ cell cancer
por: Sestakova, Zuzana, et al.
Publicado: (2016)

Prognostic value of intratumoral carbonic anhydrase IX expression in testicular germ cell tumors
por: Kalavska, Katarina, et al.
Publicado: (2017)

SARS-CoV-2 Specific Humoral Immune Responses after BNT162b2 Vaccination in Hospital Healthcare Workers
por: Golshani, Maryam, et al.
Publicado: (2022)

EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Yeast Infections: An Initiative of the European Confederation of Medical Mycology in Cooperation With the International Society for Human and Animal Mycology and American Society for Microbiology
por: Stemler, Jannik, et al.
Publicado: (2021)

Long-term sexual functioning in germ-cell tumor survivors
por: Chovanec, M., et al.
Publicado: (2020)

Neutralizing Activity of BNT162b2-Elicited Serum
por: Liu, Yang, et al.
Publicado: (2021)

BNT162b2 vaccine for prevention of COVID-19
Publicado: (2021)

Boosting BNT162b2 vaccine efficacy in CLL
por: Bhat, Seema A., et al.
Publicado: (2022)

Erythema Multiforme after BNT162b2 Vaccination
por: Katayama, Sho, et al.
Publicado: (2022)

Are Changes in the Percentage of Specific Leukocyte Subpopulations Associated with Endogenous DNA Damage Levels in Testicular Cancer Patients?
por: Kalavska, Katarina, et al.
Publicado: (2021)

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
por: Lim, Xin Rong, et al.
Publicado: (2021)

Longitudinal Analysis of SARS-CoV-2-Specific Cellular and Humoral Immune Responses and Breakthrough Infection following BNT162b2/BNT162b2/BNT162b2 and ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naive Healthcare Workers
por: Ko, Geon Young, et al.
Publicado: (2023)

Prognostic value of serum carbonic anhydrase IX in testicular germ cell tumor patients
por: Kalavska, Katarina, et al.
Publicado: (2016)

BNT-162b1: Stevens-Johnson syndrome: case report
Publicado: (2021)

Waning Immunity after the BNT162b2 Vaccine in Israel
por: Goldberg, Yair, et al.
Publicado: (2021)

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Mevorach, Dror, et al.
Publicado: (2022)

Acute interstitial nephritis after vaccination with BNT162b2
por: Rieckmann, Sonja, et al.
Publicado: (2022)

Effectiveness of BNT162b2 against COVID-19 in adolescents
por: Powell, Annabel A, et al.
Publicado: (2022)

Acute myocarditis following administration of BNT162b2 vaccine
por: Habib, Mhd Baraa, et al.
Publicado: (2021)

Beyond neutralization for BNT162b2 mRNA vaccination
por: Damani-Yokota, Payal, et al.
Publicado: (2021)

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Witberg, Guy, et al.
Publicado: (2022)

Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial
por: Mego, Michal, et al.
Publicado: (2021)

Prognostic role of plasma vitamin D and its association with disease characteristics in germ cell tumours
por: Lesko, Peter, et al.
Publicado: (2023)

Cognitive impairment and biomarkers of gut microbial translocation in testicular germ cell tumor survivors
por: Chovanec, Michal, et al.
Publicado: (2023)

Évaluation de l'immunogénicité après vaccination COVID-19 hétérologue ChAdOx1-nCoV19/BNT162b2 et homologue BNT162b2/BNT162b2– Cohorte ANRS0001S COV-POPART
por: Lachâtre, M., et al.
Publicado: (2022)

Pfizer SARS-CoV-2 BNT162b2 mRNA vaccination (BNT162b2) has no adverse effect on elective oocyte cryopreservation outcomes
por: Karavani, Gilad, et al.
Publicado: (2022)

Immune Responses After Vaccination With Primary 2-Dose ChAdOx1 Plus a Booster of BNT162b2 or Vaccination With Primary 2-Dose BNT162b2 Plus a Booster of BNT162b2 and the Occurrence of Omicron Breakthrough Infection
por: Choi, Seong-Ho, et al.
Publicado: (2023)

The temporal course of T- and B-cell responses to vaccination with BNT162b2 and mRNA-1273
por: Markewitz, Robert, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aht5mfupo9rl5011j2qcu45dgu